Cargando…

Diabetes Mellitus Is Still a Strong Predictor of Periprocedural Outcomes of Primary Percutaneous Coronary Interventions in Patients Presenting with ST-Segment Elevation Myocardial Infarction (from the ORPKI Polish National Registry)

The impact of diabetes mellitus (DM) on outcomes of patients with ST-segment elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (PCI) was confirmed by several studies. However, it is unclear whether this effect is still present in large groups of unselected...

Descripción completa

Detalles Bibliográficos
Autores principales: Dziewierz, Artur, Zdzierak, Barbara, Malinowski, Krzysztof P., Siudak, Zbigniew, Zasada, Wojciech, Tokarek, Tomasz, Zabojszcz, Michał, Dolecka-Ślusarczyk, Magdalena, Dudek, Dariusz, Bartuś, Stanisław, Surdacki, Andrzej, Rakowski, Tomasz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9657628/
https://www.ncbi.nlm.nih.gov/pubmed/36362512
http://dx.doi.org/10.3390/jcm11216284
_version_ 1784829744990126080
author Dziewierz, Artur
Zdzierak, Barbara
Malinowski, Krzysztof P.
Siudak, Zbigniew
Zasada, Wojciech
Tokarek, Tomasz
Zabojszcz, Michał
Dolecka-Ślusarczyk, Magdalena
Dudek, Dariusz
Bartuś, Stanisław
Surdacki, Andrzej
Rakowski, Tomasz
author_facet Dziewierz, Artur
Zdzierak, Barbara
Malinowski, Krzysztof P.
Siudak, Zbigniew
Zasada, Wojciech
Tokarek, Tomasz
Zabojszcz, Michał
Dolecka-Ślusarczyk, Magdalena
Dudek, Dariusz
Bartuś, Stanisław
Surdacki, Andrzej
Rakowski, Tomasz
author_sort Dziewierz, Artur
collection PubMed
description The impact of diabetes mellitus (DM) on outcomes of patients with ST-segment elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (PCI) was confirmed by several studies. However, it is unclear whether this effect is still present in large groups of unselected patients undergoing up-to-date treatment. Thus, we sought to assess the impact of DM on periprocedural outcomes of primary PCI in STEMI using data from the Polish National Registry of PCI. Data on 150,782 STEMI patients undergoing primary PCI were collected. Of them, 26,360 (17.5%) patients had DM. Patients with DM were higher-risk individuals who experienced longer reperfusion delays and were less likely to have closed infarct-related artery at baseline (TIMI 0 + 1 flow: 73.2% vs. 72.0%; p < 0.0001) and achieve optimal reperfusion after PCI (TIMI 3 flow: 91.8% vs. 88.5%; p < 0.0001). The periprocedural mortality (1.1% vs. 1.9%; p < 0.0001) was higher in patients with DM and DM was identified as an independent predictor of periprocedural death. In conclusion, despite continuous progress in STEMI treatment, DM remains a strong predictor of periprocedural mortality. However, this detrimental effect of DM may be partially explained by the overall higher risk profile of diabetic patients.
format Online
Article
Text
id pubmed-9657628
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-96576282022-11-15 Diabetes Mellitus Is Still a Strong Predictor of Periprocedural Outcomes of Primary Percutaneous Coronary Interventions in Patients Presenting with ST-Segment Elevation Myocardial Infarction (from the ORPKI Polish National Registry) Dziewierz, Artur Zdzierak, Barbara Malinowski, Krzysztof P. Siudak, Zbigniew Zasada, Wojciech Tokarek, Tomasz Zabojszcz, Michał Dolecka-Ślusarczyk, Magdalena Dudek, Dariusz Bartuś, Stanisław Surdacki, Andrzej Rakowski, Tomasz J Clin Med Article The impact of diabetes mellitus (DM) on outcomes of patients with ST-segment elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (PCI) was confirmed by several studies. However, it is unclear whether this effect is still present in large groups of unselected patients undergoing up-to-date treatment. Thus, we sought to assess the impact of DM on periprocedural outcomes of primary PCI in STEMI using data from the Polish National Registry of PCI. Data on 150,782 STEMI patients undergoing primary PCI were collected. Of them, 26,360 (17.5%) patients had DM. Patients with DM were higher-risk individuals who experienced longer reperfusion delays and were less likely to have closed infarct-related artery at baseline (TIMI 0 + 1 flow: 73.2% vs. 72.0%; p < 0.0001) and achieve optimal reperfusion after PCI (TIMI 3 flow: 91.8% vs. 88.5%; p < 0.0001). The periprocedural mortality (1.1% vs. 1.9%; p < 0.0001) was higher in patients with DM and DM was identified as an independent predictor of periprocedural death. In conclusion, despite continuous progress in STEMI treatment, DM remains a strong predictor of periprocedural mortality. However, this detrimental effect of DM may be partially explained by the overall higher risk profile of diabetic patients. MDPI 2022-10-25 /pmc/articles/PMC9657628/ /pubmed/36362512 http://dx.doi.org/10.3390/jcm11216284 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Dziewierz, Artur
Zdzierak, Barbara
Malinowski, Krzysztof P.
Siudak, Zbigniew
Zasada, Wojciech
Tokarek, Tomasz
Zabojszcz, Michał
Dolecka-Ślusarczyk, Magdalena
Dudek, Dariusz
Bartuś, Stanisław
Surdacki, Andrzej
Rakowski, Tomasz
Diabetes Mellitus Is Still a Strong Predictor of Periprocedural Outcomes of Primary Percutaneous Coronary Interventions in Patients Presenting with ST-Segment Elevation Myocardial Infarction (from the ORPKI Polish National Registry)
title Diabetes Mellitus Is Still a Strong Predictor of Periprocedural Outcomes of Primary Percutaneous Coronary Interventions in Patients Presenting with ST-Segment Elevation Myocardial Infarction (from the ORPKI Polish National Registry)
title_full Diabetes Mellitus Is Still a Strong Predictor of Periprocedural Outcomes of Primary Percutaneous Coronary Interventions in Patients Presenting with ST-Segment Elevation Myocardial Infarction (from the ORPKI Polish National Registry)
title_fullStr Diabetes Mellitus Is Still a Strong Predictor of Periprocedural Outcomes of Primary Percutaneous Coronary Interventions in Patients Presenting with ST-Segment Elevation Myocardial Infarction (from the ORPKI Polish National Registry)
title_full_unstemmed Diabetes Mellitus Is Still a Strong Predictor of Periprocedural Outcomes of Primary Percutaneous Coronary Interventions in Patients Presenting with ST-Segment Elevation Myocardial Infarction (from the ORPKI Polish National Registry)
title_short Diabetes Mellitus Is Still a Strong Predictor of Periprocedural Outcomes of Primary Percutaneous Coronary Interventions in Patients Presenting with ST-Segment Elevation Myocardial Infarction (from the ORPKI Polish National Registry)
title_sort diabetes mellitus is still a strong predictor of periprocedural outcomes of primary percutaneous coronary interventions in patients presenting with st-segment elevation myocardial infarction (from the orpki polish national registry)
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9657628/
https://www.ncbi.nlm.nih.gov/pubmed/36362512
http://dx.doi.org/10.3390/jcm11216284
work_keys_str_mv AT dziewierzartur diabetesmellitusisstillastrongpredictorofperiproceduraloutcomesofprimarypercutaneouscoronaryinterventionsinpatientspresentingwithstsegmentelevationmyocardialinfarctionfromtheorpkipolishnationalregistry
AT zdzierakbarbara diabetesmellitusisstillastrongpredictorofperiproceduraloutcomesofprimarypercutaneouscoronaryinterventionsinpatientspresentingwithstsegmentelevationmyocardialinfarctionfromtheorpkipolishnationalregistry
AT malinowskikrzysztofp diabetesmellitusisstillastrongpredictorofperiproceduraloutcomesofprimarypercutaneouscoronaryinterventionsinpatientspresentingwithstsegmentelevationmyocardialinfarctionfromtheorpkipolishnationalregistry
AT siudakzbigniew diabetesmellitusisstillastrongpredictorofperiproceduraloutcomesofprimarypercutaneouscoronaryinterventionsinpatientspresentingwithstsegmentelevationmyocardialinfarctionfromtheorpkipolishnationalregistry
AT zasadawojciech diabetesmellitusisstillastrongpredictorofperiproceduraloutcomesofprimarypercutaneouscoronaryinterventionsinpatientspresentingwithstsegmentelevationmyocardialinfarctionfromtheorpkipolishnationalregistry
AT tokarektomasz diabetesmellitusisstillastrongpredictorofperiproceduraloutcomesofprimarypercutaneouscoronaryinterventionsinpatientspresentingwithstsegmentelevationmyocardialinfarctionfromtheorpkipolishnationalregistry
AT zabojszczmichał diabetesmellitusisstillastrongpredictorofperiproceduraloutcomesofprimarypercutaneouscoronaryinterventionsinpatientspresentingwithstsegmentelevationmyocardialinfarctionfromtheorpkipolishnationalregistry
AT doleckaslusarczykmagdalena diabetesmellitusisstillastrongpredictorofperiproceduraloutcomesofprimarypercutaneouscoronaryinterventionsinpatientspresentingwithstsegmentelevationmyocardialinfarctionfromtheorpkipolishnationalregistry
AT dudekdariusz diabetesmellitusisstillastrongpredictorofperiproceduraloutcomesofprimarypercutaneouscoronaryinterventionsinpatientspresentingwithstsegmentelevationmyocardialinfarctionfromtheorpkipolishnationalregistry
AT bartusstanisław diabetesmellitusisstillastrongpredictorofperiproceduraloutcomesofprimarypercutaneouscoronaryinterventionsinpatientspresentingwithstsegmentelevationmyocardialinfarctionfromtheorpkipolishnationalregistry
AT surdackiandrzej diabetesmellitusisstillastrongpredictorofperiproceduraloutcomesofprimarypercutaneouscoronaryinterventionsinpatientspresentingwithstsegmentelevationmyocardialinfarctionfromtheorpkipolishnationalregistry
AT rakowskitomasz diabetesmellitusisstillastrongpredictorofperiproceduraloutcomesofprimarypercutaneouscoronaryinterventionsinpatientspresentingwithstsegmentelevationmyocardialinfarctionfromtheorpkipolishnationalregistry